The National Institutes of Health (NIH) posted the following on their ‘Clinical Trials’ website.

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

It appears this is a two part placebo-controlled study to determine dosage and potential safety issues as well as the any change in thigh muscle volume. The trial is to begin this month.  

I will post more information as it becomes available.